Literature DB >> 29296713

Blood volume-based von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.

Margaret V Ragni1.   

Abstract

Publisher's Note: This article has a companion Point by Kouides. Publisher's Note: Join in the discussion of these articles at Blood Advances Community Conversations.

Entities:  

Year:  2017        PMID: 29296713      PMCID: PMC5727819          DOI: 10.1182/bloodadvances.2017005090

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  30 in total

1.  Factor VIII and von Willebrand factor changes during normal pregnancy and puerperium.

Authors:  Analía Sánchez-Luceros; Susana S Meschengieser; Carlos Marchese; Roberto Votta; Patricia Casais; Adriana I Woods; María V Nadal; María J Salviú; María A Lazzari
Journal:  Blood Coagul Fibrinolysis       Date:  2003-10       Impact factor: 1.276

2.  Postpartum haemorrhage in women with von Willebrand disease: an observational study of the Pennsylvania Health Care Cost Containment Council (PHC4) database.

Authors:  L M Malec; C G Moore; J Yabes; J Li; M V Ragni
Journal:  Haemophilia       Date:  2015-07-20       Impact factor: 4.287

3.  Central hemodynamic assessment of normal term pregnancy.

Authors:  S L Clark; D B Cotton; W Lee; C Bishop; T Hill; J Southwick; J Pivarnik; T Spillman; G R DeVore; J Phelan
Journal:  Am J Obstet Gynecol       Date:  1989-12       Impact factor: 8.661

Review 4.  Maternal cardiac metabolism in pregnancy.

Authors:  Laura X Liu; Zolt Arany
Journal:  Cardiovasc Res       Date:  2014-01-20       Impact factor: 10.787

5.  von Willebrand disease and bleeding in women.

Authors:  M V Ragni; F A Bontempo; A C Hassett
Journal:  Haemophilia       Date:  1999-09       Impact factor: 4.287

6.  Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight.

Authors:  Sven Björkman; MyungShin Oh; Gerald Spotts; Phillip Schroth; Sandor Fritsch; Bruce M Ewenstein; Kathleen Casey; Kathelijn Fischer; Victor S Blanchette; Peter W Collins
Journal:  Blood       Date:  2011-10-31       Impact factor: 22.113

7.  Pharmacokinetic analysis of anti-hemophilic factor in the obese patient.

Authors:  A Graham; K Jaworski
Journal:  Haemophilia       Date:  2013-11-20       Impact factor: 4.287

8.  Reduced prevalence of arterial thrombosis in von Willebrand disease.

Authors:  Y V Sanders; J Eikenboom; E M de Wee; J G van der Bom; M H Cnossen; M E L Degenaar-Dujardin; K Fijnvandraat; P W Kamphuisen; B A P Laros-van Gorkom; K Meijer; E P Mauser-Bunschoten; F W G Leebeek
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

Review 9.  Variation of drug kinetics in pregnancy.

Authors:  Petr Pavek; Martina Ceckova; Frantisek Staud
Journal:  Curr Drug Metab       Date:  2009-06       Impact factor: 3.731

Review 10.  The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.

Authors:  Mike A Laffan; Will Lester; James S O'Donnell; Andrew Will; Robert Campbell Tait; Anne Goodeve; Carolyn M Millar; David M Keeling
Journal:  Br J Haematol       Date:  2014-08-12       Impact factor: 6.998

View more
  3 in total

1.  Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the hematologist's view.

Authors:  Margaret V Ragni
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.

Authors:  Nicoletta Machin; Margaret V Ragni
Journal:  Blood Adv       Date:  2020-07-28

3.  Significant gynecological bleeding in women with low von Willebrand factor levels.

Authors:  Michelle Lavin; Sonia Aguila; Niall Dalton; Margaret Nolan; Mary Byrne; Kevin Ryan; Barry White; Niamh M O'Connell; Jamie M O'Sullivan; Jorge Di Paola; Paula D James; James S O'Donnell
Journal:  Blood Adv       Date:  2018-07-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.